CATALAYER NEWS
MAIA Biotechnology Receives FDA’s Fast Track Designation for Ateganosine as a Treatment for Non-Small Cell Lung Cancer - Business Wire
Source: Business Wire · 2025-07-28
Full article text is available in the Catalayer news terminal.
RELATED ON CATALAYER
Related Topics
Biotech & FDA NewsRELATED MARKETS
Prediction Markets